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In humans, the connection between sleep and mood has long been
recognized, although direct molecular evidence is lacking. We
identified two rare variants in the circadian clock gene PERIOD3
(PER3-P415A/H417R) in humans with familial advanced sleep phase
accompanied by higher Beck Depression Inventory and seasonality
scores. hPER3-P415A/H417R transgenic mice showed an altered cir-
cadian period under constant light and exhibited phase shifts of the
sleep-wake cycle in a short light period (photoperiod) paradigm.
Molecular characterization revealed that the rare variants destabi-
lized PER3 and failed to stabilize PERIOD1/2 proteins, which play
critical roles in circadian timing. Although hPER3-P415A/H417R-Tg
mice showed a mild depression-like phenotype, Per3 knockout
mice demonstrated consistent depression-like behavior, particularly
when studied under a short photoperiod, supporting a possible role
for PER3 in mood regulation. These findings suggest that PER3 may
be a nexus for sleep and mood regulation while fine-tuning these
processes to adapt to seasonal changes.
circadian clock | circadian rhythms | familial advanced sleep phase |
seasonal affective disorder | PER3
In human populations, alterations in circadian timing can resultin mood-related problems (1). An example of this is seasonal
affective disorder, also known as “winter depression,” which is
among the most common mood disorders, with a reported prev-
alence of 1.5–9%, depending on latitude (2). In addition, shift
work has been suggested as a risk factor for major depressive
disorder (3), and depression severity correlates with the degree
of circadian misalignment (4, 5). A number of genetic variants in
core clock genes have been reported as statistically associated with
mood disorders, including seasonal affective disorder and major
depressive disorder (6–14), but to date none has been causally
related with an understanding of specific molecular links.
Familial advanced sleep phase (FASP) is a human behavioral
phenotype defined by early sleep time and early morning awak-
ening (15). We previously identified mutations in core clock genes
that cause FASP by linkage analysis/positional cloning (16) and
candidate gene sequencing (17, 18). Here we identify two rare
missense variants in PER3 (PER3-P415A/H417R) that cause FASP
and are associated with elevated Beck Depression Inventory
(BDI) and seasonality scores. Transgenic mice carrying human
PER3-P415A/H417R exhibit delayed phase in a short photoperiod
and a lengthened period of wheel-running rhythms in constant
light. At a molecular level, the rare variants lead to decreased
PER3 protein levels, likely due to decreased protein stability.
Moreover, we found that PER3-P415A/H417R can exert effects
on the clock (at least in part) by reducing its stabilizing effect
on PER1 and PER2. Although hPER3-P415A/H417R transgenic
mice display mild measures of depression-like phenotype, Per3−/−
mice exhibit consistent depression-like behaviors in multiple tests.
The differences are particularly evident in short photoperiods,
implying a role for PER3 in mood regulation. Taken together,
these results support a role for PER3 in modulating circadian
clock and mood that may be especially critical under conditions of
short photoperiod (e.g., during the winter season).
Results
Rare PER3 Variants Found in FASP and Seasonal Affective Disorder
Subjects. The proband of this study was noted to have advanced
sleep phase, accompanied by increased depressive mood and
global seasonality scores (GSS) (Table 1). Further assessment of
related family members revealed an autosomal-dominant trans-
mission of these traits (Fig. 1A and Table 1). A total of three
individuals were found to have FASP, with much earlier sleep
onset and offset times compared with unaffected family mem-
bers and conventional sleepers (sleep onset time, 00:15; sleep
offset time, 8:15; euclock.org). The midsleep times for these
individuals were within the earliest ∼2–3% of the general pop-
ulation (19). All three individuals had high scores on the Horne–
Ostberg Questionnaire, which assesses morning-evening prefer-
ence; individuals with a score of ≥70 are considered extreme
“morning types” (20).
All three individuals also showed clinical features of seasonal
affective disorder with mildly to moderately elevated BDI scores
(>73%∼84% of the general population) (Table 1) (21, 22). The
affected subjects exhibited characteristics of seasonal affective
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disorder with a GSS higher than that of 96.90%∼99.99% of the
general population and a high Problem Severity Score (23, 24). In
addition, two of the individuals reported that their worst months
are in the winter.
While screening candidate circadian genes for mutations re-
lated to the FASP phenotype, we identified a C-to-G change and
an A-to-G change in PER3, resulting in proline-to-alanine and
histidine-to-arginine changes at amino acids 415 and 417 of the
protein, respectively (Fig. 1B). These two rare variants (P415A
and H417R) occur at residues that are conserved in vertebrate
PER3. In addition, P415 is conserved in both PER1 and PER2,
whereas H417 is conserved only in PER1. These two missense
variants are on the same allele and cosegregate with FASP and
mood traits. They were not found in any of more than 250 control
DNA samples, although they do exist in the general population
at an allele frequency of 0.55% (1000 Genomes Project). Given
that the prevalence of major depressive episode is ∼17% in the
US (25), and because patients with depression manifest circadian
disruptions in behavior and physiology (26), we reason that the
existence of these rare variants in the public database does not
eliminate the possibility of them being causative of FASP and
seasonal affective disorder.
PER3-P415A/H417R Alters Circadian Rhythms. To test whether PER3-
P415A/H417R variants cause FASP and the mood traits instead
of merely being indirectly associated with them, we generated
hPER3-WT (hPER3-WT-Tg) and hPER3-P415A/H417R (hPER3-
P415A/H417R-Tg) transgenic mice using a human bacterial ar-
tificial chromosome (BAC) clone carrying the entire hPER3
gene. Under 12 h light/12 h dark (LD 12:12) and constant darkness
(DD) conditions, we found no substantial difference in wheel-
running rhythms between hPER3-WT-Tg and hPER3-P415A/
H417R-Tg mice (Fig. 2 A and B).
We next subjected the animals to a constant light (LL) to test
whether the rare variants alter the effects of light on the clock.
Interestingly, in contrast to Per3 knockout mice, which have a
shortened period under LL (27), the behavioral period of hPER3-
P415A/H417R-Tgmice was significantly longer than that of hPER3-
WT-Tgmice (Fig. 2 B and C). Given that one of the human subjects
displayed advanced phase only during winter, when photoperiods
are short (Table 1), we monitored hPER3-P415A/H417R-Tg mice
in 4-h light/20-h dark cycles (LD 4:20) and observed a ∼4-h phase
delay in activity onset and offset time vs. WT (Fig. 2 D–F). We
found no phase delay in wheel-running rhythms under LD 4:20 in
hPER3-WT-Tg, WT, and Per3−/− mice, however (Fig. 2 D–F).
These results support a dominant effect of PER3-P415A/H417R
over PER3-WT on the light-sensing pathway(s) in mice.
We also generated and characterized transgenic flies carrying
either WT or mutant human PER3 (Fig. S1 and Tables S1 and
S2). Interestingly, flies expressing hPER3-P415A/H417R showed
significantly earlier activity offset time compared with hPER3-
WT flies (Fig. S1A and Table S1). In addition, the period of
activity rhythms was significantly shorter in the hPER3-P415A/
H417R flies under DD (Fig. S1A and Table S2). These results
suggest that the hPER3-P415A/H417R produces similar effects
on diurnal flies as those seen in human FASP subjects.
PER3-P415A/H417R Has Reduced Repressor Activity and Is Less Stable
Than PER3-WT. To test whether the rare variants affect PER3 re-
pressor activity, we used a Per2 promoter-driven luciferase reporter
assay to determine the repressive activity of WT and P415A/H417R
PER3 proteins. PER3-P415A/H417R demonstrated consistently
reduced repressor activity compared with PER3-WT, suggesting
that these variants make PER3 a weaker repressor (Fig. 3A).
Based on the persistently lower levels of mutant protein
compared with WT protein (Fig. 3B), we tested whether the rare
variants affect PER3 by altering protein stability. Through con-
tinuous recording of bioluminescence activity, we found that the
bioluminescence decay of PER3-LUC after treatment with a
protein synthesis inhibitor, cycloheximide (CHX), was signifi-
cantly accelerated by the P415A/H417R variants (Fig. 3C). On
Western blot analysis, we also found that relative FLAG-PER3-
P415A/H417R protein level was lower after CHX treatment
compared with that of PER3-WT (Fig. 3D), indicating that
P415A/H417R variants destabilize PER3 protein.
To determine whether the PER3-P415A/H417R protein levels
in transgenic animal models are also altered in vivo, we assessed
hPER3 levels for hPER3-WT-Tg and hPER3-P415A/H417R-Tg
mice. Nuclear hPER3 protein levels were significantly lower in
Table 1. Clinical variables of the human subjects
Subject Age, y Status Sleep onset Sleep offset
Mid-sleep
time on free days HO score BDI score GSS
Problem
Severity Score
Worst month(s)
of the year
42637* 68 C 19:30 2:30 23:00 78 18 13 4 December, January
101334 67 C 21:33 5:30 1:32 73 15 10 2 No worst month
100726 48 C 19:00 (winter) 3:00 (winter) 23:00 (winter) 68 21 18 3 December
00:00 (summer) 8:00 (summer) 4:00 (summer)
101323 45 NC 23:07 7:45 3:26 52 3 1 0 No worst month
C, mutation carrier; NC, nonmutation carrier, HO, Horne–Ostberg.
*Proband.
A
B
Fig. 1. FASP pedigree and the amino acid alignment around the rare var-
iants. (A) FASP kindred 7107. Circles represent women; squares, men. Filled
symbols denote affected individuals; open symbols, unaffected individuals.
Symbols marked with a cross are unknown (i.e., do not meet criteria for
affected or unaffected). Diagonal lines through symbols indicate that the
individual is deceased. Subject 42637 is the proband. (B) Alignments for
human (h) and mouse (m) PER proteins in the region harboring the variants.
The P415A/H417R variants are highlighted.
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Fig. 2. Expression of PER3-P415A/H417R in mice lengthens the period and delays the phase of activity rhythm. (A) Wheel-running activity profiles of
hPER3-WT-Tg and hPER3-P415A/H417R-Tg mice during LD 12:12 (n = 7–13). (B) The period of wheel-running activity under LL and DD conditions, respectively
(n = 7–29). *P < 0.05, Student’s t test. (C) Double-plotted actograms of wheel-running activity (black bars) for representative hPER3-WT-Tg and hPER3-P415A/
H417R-Tgmice. Gray areas indicate periods of darkness before release into LL. (D) Double-plotted actograms of wheel-running activity for representative WT,
Per3−/−, hPER3-WT-Tg, and hPER3-P415A/H417R-Tg mice during LD 4:20. (E) Wheel-running activity profiles of WT, hPER3-P415A/H417R-Tg, and Per3−/− mice
(Upper) and WT and hPER3-WT-Tgmice (Lower) during LD 4:20 (n = 6–20). (F) Activity onset and offset time under LD 4:20 (n = 6–20). *P < 0.05, ***P < 0.005,
Student’s t test. The white bars indicate light periods; black bars, dark periods. Error bars represent SEM.
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the hPER3-P415A/H417R-Tg mice compared with the hPER3-
WT-Tg mice (Fig. 3E). hPER3 protein levels in cytoplasmic
fractions were comparable in the two mouse strains, even though
hPER3 RNA expression level was twofold to threefold greater in
the hPER3-P415A/H417R-Tg mice (Fig. 3F). Similarly, hPER3
levels were significantly lower in hPER3-P415A/H417R com-
pared with PER3-WT transgenic flies (Fig. S2 A–C). These re-
sults indicate that consistent with in vitro data, P415A/H417R
variants lead to decreased hPER3 protein levels in vivo as a
result of decreased protein stability.
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Fig. 3. P415A/H417R variants destabilize PER3. (A) Repressor activity of WT or P415A/H417R PER3 protein on CLOCK-BMAL1–mediated expression of Per2
promoter-driven luciferase was examined by a reporter assay performed in HEK293T cells (n = 3). Luciferase activity was normalized to activity levels in the
absence of CLOCK and BMAL1 (white column). Addition of CLOCK and BMAL1 resulted in a nearly 10-fold increase in luciferase activity (black column). PER3-
P415A/H417R had reduced repressor activity across different titers compared with PER3-WT. PER2 (red column) and CRY2 (yellow column) were positive
controls for repressor activity. ***P < 0.001, two-way ANOVA. (B) PER3 protein levels in the nuclear and the cytoplasmic fractions. HEK293T cells were
transfected with indicated plasmid vectors. At 48 h after transfection, the cells were harvested and then fractionated into nuclear and cytoplasmic fractions.
Results are expressed as mean ± SEM (n = 3). **P < 0.01, ***P < 0.005, Student′s t test. (C) HEK293T cells were transfected with indicated plasmid vectors. At
24 h after transfection, the culture medium was replaced by measuring medium containing CHX (100 μg/mL). Bioluminescence was measured at 10-min
intervals. Bioluminescence at time point 0 was set to 1. Half-lives of PER3-LUCs were calculated by fitting the bioluminescence signals to exponential func-
tions. Error bars show mean ± SEM (n = 3). **P < 0.01, Student’s t test. (D) HEK293T cells were transfected with indicated plasmid vectors. At 40 h after
transfection, the cells were treated with CHX (100 μg/mL) for 4 or 8 h. PER3 protein levels at time point 0 were set to 1, and relative PER3 protein levels were
plotted. Error bars showmean ± SEM (n = 3). ***P < 0.005, Student’s t test. (E) Western blots of nuclear and cytoplasmic fractions of liver extracts from hPER3-
WT-Tg and hPER3-P415A/H417R-Tg mice at ZT12. LMNB1 and β-actin served as loading controls in the nuclear and cytoplasmic fractions, respectively. Nuclear
PER3 protein levels were normalized to LMNB1 levels and are expressed as mean ± SEM (n = 3 per genotype). *P < 0.05, Student′s t test. (F) Expression levels
of hPER3mRNA in liver extracts from hPER3-WT-Tg and hPER3-P415A/H417R-Tg animals (n = 5 per genotype), as assayed by three independent TaqMan qPCR
assays across different exon boundaries. Expression levels in hPER3-P415A/H417R-Tg mice were normalized to those in hPER3-WT-Tg mice. Results are
expressed as mean ± SEM. **P < 0.01, ***P < 0.001, Student’s t test.
4 of 9 | www.pnas.org/cgi/doi/10.1073/pnas.1600039113 Zhang et al.
PER3-P415A/H417R Has Reduced Ability to Stabilize PER1 and PER2.
Previous studies have demonstrated that PER3 functions to
promote nuclear translocation of PER1 and PER2 (28). We
tested whether mutant PER3 exerts any influence on the clock by
impinging on nuclear/cytoplasmic distribution of PER1 and/or
PER2. We assessed nuclear and cytoplasmic mPER1 and mPER2
protein levels in hPER3-WT-Tg and hPER3-P415A/H417R-Tg
mice and found that mPER1 levels were significantly reduced in
cytoplasmic fractions from the hPER3-P415A/H417R-Tg mice, but
that the differences for nuclear fractions did not reach statistical
significance (Fig. S3). In addition, mPER2 levels were significantly
lower in both the nuclear and cytoplasmic fractions of hypothal-
amus from the hPER3-P415A/H417R-Tg mice (Fig. 4A). We also
observed a similar trend for mPER2 in the liver, although it did
not reach statistical significance for the cytoplasmic fractions (Fig.
4B). Thus, PER1 and PER2 levels are lower in the presence of
PER3-P415A/H417R vs. PER3-WT in vivo. Even though the
Drosophila PER protein sequence is poorly conserved in this
region, dPER protein is affected by the human variants; we found
that dPER protein levels were significantly lower in hPER3-
P415A/H417R flies compared with hPER3-WT flies.
To further explore the effects of PER3-P415A/H417R on PER1/
PER2, we coexpressed hPER1/hPER2 with hPER3-WT or hPER3-
P415A/H417R in HEK293T cells and then treated the cells with
CHX. We measured the half-lives of PER1 and PER2 through
a bioluminescence degradation analysis. Interestingly, PER3-WT
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Fig. 4. PER3-P415A/H417R has reduced ability to stabilize PER1/PER2. (A and B) (Left) representative Western blots of PER2 in nuclear and cytoplasmic
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mean ± SEM (n = 3). *P < 0.05, Student’s t test.
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stabilized PER1 and PER2, whereas PER3-P415A/H417R failed
to do so (Fig. 4C). Similarly, using Western blot analysis, we
found that PER3-WT, but not PER3-P415A/H417R, significantly
increased PER2 protein stability (Fig. 4D). These results imply
that PER3-WT acts to promote the stability of PER1/PER2, and
that the PER3 variants abrogate this effect, leading to lower
levels of PER1 and PER2. Taken together, these results suggest
that the rare variants may act through PER1 and PER2 to alter
clock regulation.
PER3-P415A/H417R Mice Have Altered Sleep and Increased Depression-
Like Behavior on the Tail Suspension Test. Given that the human car-
riers of rare PER3 variants show features of seasonal affective dis-
order, we tested whether transgenic mice can recapitulate this
phenotype. When subjected to the tail suspension test, hPER3-
P415A/H417R-Tg mice exhibited a significantly increased duration
of immobility compared with WT littermates, indicating increased
depression-like behavior (Fig. 5A). This finding cannot be related
simply to overexpression of hPER3 in mice, given that hPER3-WT-
Tg transgenic mice are indistinguishable from WT mice (Fig. 5B).
Moreover, the increased duration of immobility in hPER3-P415A/
H417R-Tg mice was suppressed in a dose-dependent manner by
treatment with the antidepressant imipramine (Fig. 5C), indicating
that the depression-like behavior observed in these animals shares
pharmacologic similarities with human depression. We did not de-
tect any significant changes using the forced swim and sucrose in-
take tests, however.
Because patients with depression often experience disruptions
in sleep (29), we also assessed sleep in our mouse models by
evaluating electroencephalography (EEG) and electromyogra-
phy (EMG) findings. Under LD cycles, hPER3-P415A/H417R-Tg
mice spent significantly more time awake in the dark phase rel-
ative to WT mice, accompanied by significantly less nonrapid eye
movement (NREM) sleep in the dark phase and less rapid eye
movement (REM) sleep in the light phase (Fig. S4 A1–A3). In
addition, compared with WT mice, hPER3-P415A/H417R-Tgmice
had a significantly longer average length of wake episodes in the
dark phase, along with a significantly shorter average length of
REM sleep episodes in both the light and dark phases (Fig. S4
A4–A6). Despite the differences in sleep quantity, we found no
significant change in NREM δ power or REM θ power, suggesting
that sleep depth was not altered in the hPER3-P415A/H417R-Tg
mice (Fig. S4 A7 and A8). These effects on sleep are exerted by
the P415A/H417R variants, given that hPER3-WT expression in
mice did not significantly alter sleep (Fig. S4B). Interestingly,
sleep amount did not differ significantly between hPER3-P415A/
H417R-Tg and WT mice under DD, implying that the hPER3-
P415A/H417R allele alters sleep in a light-dependent manner.
We next examined whether hPER3-P415A/H417R influences
the regulation of sleep homeostasis by sleep-depriving mice for
6 h starting at the beginning of the light phase (i.e., when the
animals normally sleep) and monitoring recovery sleep during
the next 18 h (the subsequent 6 h of the light phase and 12 h of
the dark phase). WT, hPER3-WT-Tg, and hPER3-P415A/H417R-
Tg mice all exhibited comparable sleep rebound, with no sig-
nificant alteration among the different genotypes (Fig. S4 C and
D), suggesting that sleep homeostasis is not affected by the
hPER3-P415A/H417R variants.
Per3 Knockout Mice Display Depression-Like Behavior in a Short
Photoperiod. Because P415A/H417R variants destabilize PER3
protein, we tested whether the mood phenotype is associated with
a reduction of PER3. Given that hPER3-P415A/H417R-Tg mice
have two copies of endogenous mPer3 and two or three copies
of the hPER3-P415A/H417R transgene, transgenic mice over-
expressing PER3 are not a good model for a mutation leading to
reduced PER3. Thus, we tested Per3 −/− mice for depression-like
behavior. Under LD 12:12, Per3−/− mice displayed significantly
increased duration of immobility in the tail suspension test and
no significant change in the forced swim test (Fig. 6 A–C). When
subjected to a shortened photoperiod (LD 4:20), Per3−/− mice
demonstrated an even greater difference in the duration of im-
mobility in the tail suspension test (Fig. 6A). In addition, Per3−/−
mice showed a significantly reduced latency to immobilization
accompanied by increased duration of immobility in the forced
swim test under LD 4:20, indicative of increased depression-like
behavior (Fig. 6 B and C). We were able to rescue both of these
phenotypes with imipramine treatment (Fig. 6 D and E).
We also analyzed the hedonic value of sucrose, and found that
Per3−/− mice ingested significantly less sucrose solution (Fig. 6F),
further supporting increased depression-like behavior in these
animals. Taken together, these behavioral alterations demon-
strate a fascinating association of PER3 genotypes with mood
phenotypes, particularly in short photoperiods that mimic the
winter months. These phenotypes are reminiscent of the mood
and seasonality traits observed in the human carriers of the rare
PER3 variants, suggesting that PER3-P415A/H417R may play a
role in the seasonal affective behavior in these individuals.
Discussion
There have been numerous reports of genetic associations be-
tween polymorphisms in clock genes and psychiatric disorders
(including major depressive disorder and seasonal affective dis-
order) (6–14), but neither direct causal mutations nor molecular
pathways have been identified. We previously reported that in a
FASP kindred with a mutation in casein kinase 1δ, four of the
five affected individuals exhibited higher depression scores (17);
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however, the mutant mice carrying the casein kinase 1δ mutation
were not phenotyped for depression-like behavior. Here we de-
scribe rare hPER3 variants, P415A and H417R, that cause FASP
and provide data supporting a possible role of these variants in
seasonal affective disorder.
Given the small size of the human family and limitations of
testing “depression” in rodent models, we must be careful in
interpreting a causal role for PER3 variants in regulation of af-
fect. Nonetheless, it is striking that this PER3 allele cosegregates
with seasonal affective disorder in this small family, and that mouse
models mimicking human mutations (hPER3-P415A/H417R-Tg
and Per3−/− mice) exhibit measures of increased depression-like
behavior. This phenotype was exacerbated by subjecting animals to
a short photoperiod. Thus, this report provides evidence support-
ing the assertion that circadian rhythm and mood regulation share
common, or closely related, pathways.
We found that the period for hPER3-P415A/H417R-Tg mice
was lengthened under LL, although their behavioral rhythms
were not significantly altered in LD 12:12 and DD. Light, when
administered at different times of the day, can lead to phase
advance or delay of sleep-wake rhythms. It is believed that when
subjected to LL, an animal with a greater phase delay zone and a
smaller phase advance zone will demonstrate in period lengthening,
and vice versa (30). Our results indicate that light induces a larger
phase delay and/or smaller phase advance in hPER3-P415A/
H417R-Tg vs. hPER3-WT-Tg mice, and that the variants lead to
altered entrainment in response to light. Altered entrainment is
further supported by the observation that hPER3-P415A/H417R-
Tg mice display a large phase delay under LD 4:20.
Based on the morning/evening oscillator model, the morning
oscillator is accelerated by light, whereas the evening oscillator is
decelerated by light (30). Mice lacking PER3 exhibit a shorter
period than WT mice in LL (27), suggesting that PER3 functions
in the evening oscillator. The hPER3-P415A/H417R-Tg mice
exhibited a lengthened period in LL, supporting enhanced
function in the evening oscillator. One important function of
morning and evening oscillators is to adapt to seasonal changes
in day length (30). It is possible that PER3-P415A/H417R affects
the evening oscillators, resulting in maladaptation of activity
rhythms to short photoperiods during the winter months.
Unlike Per1- and Per2-deficient mice, Per3-deficient mice ex-
hibit relatively small changes in circadian period length in DD
(31, 32); therefore, Per3 has been considered dispensable for the
circadian clock. Polymorphisms for human PER3 have been re-
peatedly linked to diurnal preference by association studies,
however (33–36). Here we find that PER3-WT could stabilize
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PER1/PER2, and that PER3-P415A/H417R lost this ability. This
provides a possible means through which PER3-P415A/H417R
can exert an effect on the molecular clock through its loss of
stabilizing function on PER1/PER2.
The hPER3-P415A/H417R-Tg mice showed increased de-
pression-like behavior only in the tail suspension test, whereas
Per3−/− animals displayed depression-like changes in multiple
behavioral tests. Given that the P415A/H417R variants destabilize
PER3 protein, it is possible that the PER3-P415A/H417R con-
tributes to a mood phenotype in humans owing to reduced PER3
levels. Consistent with this idea, the Per3 null animals had a
stronger phenotype but exhibited a loss of both alleles. We cannot
rule out the possibility that PER3-P415A/H417R variants exert a
weak dominant-negative effect. These mouse behavioral pheno-
types become more evident in short photoperiods, reflecting an
effect of day length on mood-like behaviors that recapitulates the
mood and seasonality traits in human subjects. These findings
suggest that PER3 modulates mood to accommodate for the short
day length in winter. More work is needed to substantiate this
finding and, if verified, to characterize the molecular pathways
leading to this phenotype.
hPER3-P415A/H417R-Tg mice also exhibited reduced baseline
NREM sleep in the dark phase and REM sleep in the light
phase. The duration of REM episodes was decreased in both the
light and the dark phases. Overall recovery sleep following sleep
deprivation was not altered in these animals, indicating that sleep
homeostasis is not affected by these variants; however, the cu-
mulative REM loss from sleep deprivation tended to be much less
for hPER3-P415A/H417R-Tg mice than for control mice. These
results might be relevant to the finding of enhanced arousal in
depressed patients and the idea that depression symptoms can be
alleviated by increasing sleep propensity via sleep deprivation (37).
This increased wakefulness also may contribute to altered signal-
ing of arousal-dependent factors to the clock. Moreover, the sleep-
reducing effects of mutant PER3 are light dependent (observed
only in LD and not in DD). Consistent with our findings, it has
been suggested that a polymorphism in PER3 is involved in
modulating the alerting effects of light and the influence of light
on sleep in human subjects (38, 39).
In summary, our results suggest that PER3 serves as a node
linking the regulatory processes of circadian rhythms with those of
mood. PER3 may participate in modulating these processes to adapt
to the short photoperiods in winter. Our animal models provide
unique opportunities to further dissect the mechanisms underlying
the circadian clock and mood, and to understand the pathology that
contributes to affective disorders accompanied by altered sleep/wake
rhythms. New insights into PER3 function could have implications
for the development of treatment for affective disorders.
Materials and Methods
Additional information on the materials and methods used in this study is
provided in SI Materials and Methods.
Patient Diagnosis. Subjects signed a consent form approved by the In-
stitutional Review Boards at the University of Utah and the University of
California, San Francisco. Self-reported habitual sleep-wake schedules were
obtained from telephone interviews and/or questionnaire reports of vacation
or weekend sleep schedules. Midsleep time on free days was calculated as the
average of the habitual initial sleep onset and final awakening times during
nonwork days. More details are provided in SI Materials and Methods.
Identification of Rare Variants in PER3. We collected human families that
exhibit the trait of habitual early spontaneous awakening segregated in an
autosomal dominant pattern. To identify the mutations responsible for this
phenotype, we used a candidate gene approach to screen at least one DNA
sample from each family. We sequenced CLOCK, BMAL1, PER1-3, CRY1-2,
DEC1-2, CK1δ/«, and other known clock genes. PER3-P415A/H417R variants
were found only in this family (out of 60 families). No other circadian can-
didate gene mutations were found in this FASP family. Sequencing included
at least 100 bases flanking exons of all candidate genes.
Plasmid Construction. Detailed information on plasmid construction is pro-
vided in SI Materials and Methods.
Generation of Transgenic Mice. hPER3-WT-Tg (carrying a WT human PER3
gene) and hPER3-P415A/H417R-Tg (carrying a human PER3 gene with vari-
ants) transgenic mice were generated as described previously (17). All mouse
work was performed in accordance with the guidelines of Institutional
Animal Care and Use Committee at University of California, San Francisco.
More details are provided in SI Materials and Methods.
Mouse Wheel-Running Activity Monitoring and Analyses. This experiment was
performed using male mice (aged 2–6 mo) of the following genotypes on a
C57BL6 background: WT, hPER3-WT-Tg, hPER3-P415A/H417R-Tg, and Per3−/−
(32). Mouse housing, handling, and wheel-running activity monitoring were
performed as described previously (17). The activity onset and offset times
were calculated using standard parameters in the ClockLab software. The
default template was 6 h of inactivity followed by 6 h of activity for onsets
(and vice versa for offsets). To calculate the time of onset or offset of wheel-
running activity in LD 4:20, the largest 1-h increase or decrease in activity for
each mouse was determined. The time designation refers to the end point of
the maximal activity decrease or increase, as averaged among individual mice
in each genotype. “Phase delay” is the hours of delayed-onset Zeitgeber time
(ZT), calculated by comparing mutant transgenic mice with control mice. All of
the mice used in this work were on a C57BL6 background except the mice
shown in Fig. 2 E and F, Bottom, which were on a C57/SJL hybrid background.
More information is available in SI Materials and Methods.
qRT-PCR of Mouse Liver. Total RNA was isolated using the miRNeasy Mini Kit
(Qiagen) from liver samples of transgenic animals at ZT12. qRT-PCR was
performed as follows. After generation of cDNA by SuperScript III (Life
Technologies), duplex TaqMan qPCR assays were performed in triplicate with
probes specific for genes of interest and an endogenous control, Gapdh (Life
Technologies; 4308313). Data were calculated using the standard curve
method. Expression levels of genes of interest were then normalized to levels of
Gapdh. PER3 TaqMan assays were purchased from Integrated DNA Technology.
Luciferase Assay.HEK293T cells were transfected with a Per2::luc reporter and
other expression constructs (100 ng per well of a 24-well plate, unless noted
otherwise). For Per2 expression, 200 ng of the construct was used. For PER3
titration, 200, 50, or 12.5 ng of the construct was used for transfection. A
constitutively expressed Renilla luciferase construct served as a control. Assays
were performed at 24 h posttransfection using the Promega Dual-Luciferase
Reporter Assay System according to the manufacturer’s instructions. Results
are expressed as mean ± SEM. All experiments were performed at least twice,
and all data presented are the average of three technical replicates.
Protein Extraction and Western Blot Analysis. Nuclear and cytoplasmic protein
extraction was performed using the Active Motif Nuclear Extract Kit. For whole-
cell extracts, HEK293 cells were homogenized in RIPA buffer [25mM Tris·HCl pH
7.6, 150 mM NaCl, 1% Nonidet P-40, 1% sodium deoxycholate, 0.1% SDS,
protease inhibitor mixture (Roche), and phosphatase inhibitor mixture (Active
Motif)]. After centrifugation, supernatants were boiled for 5 min in SDS sample
buffer and then separated by SDS/PAGE. After transfer to nitrocellulose
membranes and blocking with Odyssey blocking buffer (LI-COR Biosciences),
proteins were detectedwith appropriate antibodies (SI Materials andMethods).
Nuclear PER3/PER1/PER2 was normalized to LMNB1, and cytoplasmic PER3/PER1/
PER2 was normalized to caspase 3, GAPDH, or β-actin. For whole-cell extracts,
PER3/PER2 was normalized to GAPDH or β-actin. The values of PER3-WT were
set to 1. Further details are provided in SI Materials and Methods.
Transient Transfection and Protein Stability Assays. HEK293T cells were plated
in 12-well plates and transfected with Lipofectamine 3000 transfection
reagent (Life Technologies). The following DNA constructs were used for
transfections: pCMV10-FLAG-hPER3-WT, pCMV10-FLAG-hPER3-P415A/H417R,
and pCS2-myc-hPER2 (40). Approximately 40 h later, CHX (100 μg/mL; Santa
Cruz Biotechnology) was added, and cells were harvested at 4 or 8 h after
CHX treatment.
Bioluminescence Degradation Assay. hPER1-LUC, hPER2-LUC and hPER3-LUC
fusion protein-expressing vectors were created by inserting cDNA coding the
Per-Luc gene between EcoRI and BamHI sites in the p3XFLAG-CMV-10
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vector. HEK293T cells were transfected with PER-LUC vectors and cultured
for 24 h. The cultured medium was exchanged with the recording medium
[phenol-red free DMEM (Sigma Aldrich) supplemented with 10% (vol/vol)
FBS, 3.5 mg/mL glucose, 25 U/mL penicillin, 25 μg/mL streptomycin, 0.05
mM luciferin, and 10 mM Hepes-NaOH; pH 7.0] containing 100 μg/mL CHX
(Santa Cruz Biotechnology). Luciferase activity of PER-LUC was recorded at
10-min intervals at 37 °C with a LumiCycle luminometer (Actimetrics). The
luminescence signals were fitted to exponential functions to quantify the
half-life of PER-LUC.
Tail Suspension Test, Forced Swim Test, and Sucrose Intake Test. These tests are
described in SI Materials and Methods.
Surgery and EEG/EMG Monitoring and Analysis. Surgery, EEG/EMGmonitoring,
and EEG data acquisition were performed in the indicated number of 6- to
7-mo-old mice in the Stanford Sleep and Circadian Neurobiology Laboratory
as described previously (41). Wakefulness was determined by low-amplitude,
mixed-frequency (>4 Hz) EEG with continuous large fluctuation in EMG.
Slow-wave or NREM sleep was determined by high-amplitude, low-fre-
quency (0.25–4 Hz) EEG with no fluctuation in EMG, and REM sleep was
determined by low-amplitude, high-frequency EEG (similar to the wake
stage, but with rhythmic α waves at 8–9 Hz) with no fluctuation in EMG. For
power spectral analysis, NREM δ and REM θ EEG power were analyzed with
fast Fourier transform for band frequencies between 0.25 and 4 Hz and
between 4 and 9 Hz, respectively.
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